2-{(3R,5R)-3-[3-(3-Chloro-phenyl)-ureido]-2-oxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b]azepin-1-yl}-N-(1-methyl-1-phenyl-ethyl)-acetamide

InChIKey	`DVASHPOLPKOKGD-FQLXRVMXSA-N`
Compound Name	2-{(3R,5R)-3-[3-(3-Chloro-phenyl)-ureido]-2-oxo-5-phenyl-2,3,4,5-tetrahydro-benzo[b]azepin-1-yl}-N-(1-methyl-1-phenyl-ethyl)-acetamide
Canonical SMILES	`CC(C)(NC(=O)CN1C(=O)[C@H](NC(=O)Nc2cccc(Cl)c2)C[C@H](c2ccccc2)c2ccccc21)c1ccccc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	7.97
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P32238	CCKAR	Homo sapiens	Human	PF00001 PF09193	8.0	pIC50	TTD_MultiTarget
P32239	CCKBR	Homo sapiens	Human	PF00001	8.0	IC50	ChEMBL;BindingDB